Subscribe to the newsletters
Free, by email. No account needed. Pick one or both.
No spam. Unsubscribe anytime by emailing team@midu.si. Want alerts and full data? Sign up free (separate from the newsletter). Privacy.
OMass Therapeutics, a University of Oxford spin-out developing small-molecule drugs.
Why it matters: The round shows how European biotech investors are concentrating capital on platform-based drug discovery, with OMass's native mass spectrometry approach now funded through Phase 2.
British clinical-stage biopharma company Microbiotica announced the first close of a €42 million Series C round led by British Business Bank.
Why it matters: Microbiotica's Series C first close shows how genomics and machine learning are moving microbiome drug candidates into Phase 2 trials.
Ramp raised $1.85 billion in a round co-led by Dragoneer, Thrive Capital, Founders Fund.
Why it matters: Ramp's four-month jump from a $44B to a $60B valuation shows how fast AI-adjacent fintech revenue is compounding, and where its token-spend ambitions may collide with model providers.
Stand, a San Francisco home insurer, raised a $70 million Series C at a $1 billion valuation led by Saga Ventures.
Why it matters: Stand's digital-twin pricing shows how physics simulation and a world model can replace zip-code risk scoring, with its own backtest as the only evidence.
Abby Care, an AI-native home care startup that trains family members to become certified.
Why it matters: Abby Care's $82M Series C shows investors backing an AI-native Medicaid provider that trains and pays family caregivers, a model aimed at the home care labor gap.
Modal Labs raised $750M in a Series D led by Accel, with Kleiner Perkins and existing investors.
Why it matters: Modal's Series D and disclosed revenue mix show how hosted container infrastructure is becoming a paid layer for training and agent workloads.
Chemical sourcing startup Scimplify raised $25 million in a Series C led by Hitachi Ventures.
Why it matters: Scimplify's Series C shows how AI process tools like Scinode are drawing strategic chemical-industry investors, with customer Henkel joining the round.
Hamburg-based 1KOMMA5° raised €70M from existing and new investors at a $1.35B valuation.
Why it matters: The round shows how a hardware-led energy installer is pitching its Heartbeat AI software to public-market investors, with a US entry and IPO both tied to 2027 results.
TypeSafe AI, maker of the non-text model Jev, raised $870 million at a $7.5 billion valuation led by Andreessen Horowitz.
Why it matters: TypeSafe's $870M round at a $7.5B valuation weeks after Jev's launch shows how fast enterprise buyers are testing non-LLM automation models.
Valon, a mortgage servicing platform that uses AI agents to automate loan servicing workflows.
Why it matters: Valon's $150M Series D shows investors backing AI agents applied to mortgage servicing, a regulated workflow where automation adoption is still early.
Whoop closed a $575 million Series G led by Collaborative Fund at a $10.1 billion valuation.
Why it matters: Whoop's $575M Series G at a $10.1B valuation, nearly triple its prior mark, shows how subscription wearables are drawing sovereign funds and health institutions into consumer fitness.
Supabase raised $100 million at a $5 billion valuation, just months after closing $200 million at a $2 billion valuation. On TechCrunch's Equity podcast.
Why it matters: Supabase's decision to decline large enterprise contracts while raising at a $5B valuation offers a concrete look at how infrastructure startups are positioning themselves in the vibe-coding boom.
Redwood Materials raised a $350 million Series E led by Eclipse, with a new strategic investment from Nvidia's venture arm NVentures. A source put the valuation at about $6 billion.
Why it matters: Redwood's $350M round and Nvidia's participation show how retired EV batteries are being repurposed to supply power for AI data centers.
Subscribe to the newsletters
Free, by email. No account needed. Pick one or both.
No spam. Unsubscribe anytime by emailing team@midu.si. Want alerts and full data? Sign up free (separate from the newsletter). Privacy.
Not investment advice. Midu summarizes public reports and SEC filings for information only. · Free API · Pricing
